Replies to post #519489 on NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

“Oh, I have never seen anybody bother to disclose a PIP though”

I hate to agree with you, but good point. Smells desperation to some degree as they want to sell more C shares. Another reason why I believe we do not have any major near term catalysts on horizon. Otherwise there is no point in PRing it, if MAA was going to be accepted anytime soon! Like you say, no company does a PR (or pump) on PIP news!!!

This is a bit similar to the series of PRs (hype) we saw last year (summer & fall) around manufacturing certification for specials program. Less than $2M in specials (compassionate use) revenue in the last 9 months since approval!

[sentiment_stocks]

How many times have you observed someone disclose a PIP with the intent to use the same SAP filed for a separate trial (e.g. the DCVax-L P3 trial: and late, but while still blinded), and subsequently indicate the use of External Control Arms (ECAs) that were matched in the same manner that the same separate trial used?

Oh wait, lemme answer that as you likely won't, probably never.

Which are the reasons why the company would have considered announcing the acceptance of the PIP trial to be a "material event" ... at least to our shareholders; despite the fact that you'll find no SEC rules which indicate the approval of a PIP trial is a material event. My point being that the company considered the approval of their PIP to be a material event, and so they PR'd it.